| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
115,717,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,565,825 |
Avg
Vol: |
726,369 |
| 52
Week Range: |
$2.39 - $2.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lindsay Ronald M |
Executive VP, R&D |
• • – |
2013-06-19 |
4 |
D |
$4.22 |
$41,272 |
D/D |
(9,780) |
194,608 |
|
- |
|
| Lindsay Ronald M |
Executive VP, R&D |
• • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
204,388 |
|
- |
|
| Monko Alexander Michael |
Sr. VP, Genetic Analysis |
• – – |
2013-06-19 |
4 |
D |
$4.22 |
$13,880 |
D/D |
(3,289) |
34,074 |
|
- |
|
| Monko Alexander Michael |
Sr. VP, Genetic Analysis |
• – – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
37,363 |
|
- |
|
| Van Den Boom Dirk |
Sr. VP, R&D |
• – – |
2013-06-19 |
4 |
D |
$4.22 |
$21,146 |
D/D |
(5,011) |
38,710 |
|
- |
|
| Van Den Boom Dirk |
Sr. VP, R&D |
• – – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
43,721 |
|
- |
|
| Welch William J |
Sr. VP, Diagnostics |
• – – |
2013-06-19 |
4 |
D |
$4.22 |
$14,010 |
D/D |
(3,320) |
13,215 |
|
- |
|
| Welch William J |
Sr. VP, Diagnostics |
• – – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,833 |
16,535 |
|
- |
|
| Maier Paul V |
Chief Financial Officer |
• – – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
6,666 |
59,777 |
|
- |
|
| Pendarvis David |
Director |
– • – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
35,973 |
|
- |
|
| Lai Goldman Myla |
Director |
– • – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,458 |
15,458 |
|
- |
|
| Lai Goldman Myla |
Director |
– • – |
2012-11-29 |
4 |
B |
$4.62 |
$9,238 |
D/D |
2,000 |
4,000 |
2.39 |
- |
|
| Lai Goldman Myla |
Director |
– • – |
2012-11-28 |
4 |
B |
$4.57 |
$9,138 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| Fazio John A |
Director |
– • – |
2012-11-26 |
4 |
B |
$4.45 |
$8,900 |
D/D |
2,000 |
26,019 |
2.39 |
- |
|
| Bowen R William |
Sr VP & General CounselOfficer |
• – – |
2012-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| Slacik Charles P |
Director |
– • – |
2012-08-08 |
4 |
B |
$3.24 |
$16,200 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| Fazio John A |
Director |
– • – |
2012-08-07 |
4 |
B |
$3.33 |
$6,660 |
D/D |
2,000 |
24,019 |
2.39 |
- |
|
| Beaver Carolyn |
VP and Chief Accounting Office |
• – – |
2012-08-03 |
4 |
B |
$3.13 |
$31,299 |
I/I |
10,000 |
10,000 |
1.99 |
- |
|
| Maier Paul V |
Chief Financial Officer |
• – – |
2012-08-01 |
4 |
B |
$2.81 |
$28,634 |
I/I |
10,000 |
10,000 |
1.99 |
- |
|
| Lindsay Ronald M |
Exec VP, R&D |
• • – |
2012-08-01 |
4 |
B |
$2.87 |
$299,213 |
D/D |
100,000 |
167,243 |
2.81 |
- |
|
| Hixson Harry F Jr |
CEO |
• • – |
2012-08-01 |
4 |
B |
$2.92 |
$146,150 |
I/I |
50,000 |
50,000 |
2.66 |
- |
|
| Fazio John A |
Director |
– • – |
2012-06-06 |
4 |
B |
$3.65 |
$2,920 |
D/D |
800 |
22,019 |
2.31 |
- |
|
| Fazio John A |
Director |
– • – |
2012-05-17 |
4 |
B |
$4.97 |
$4,970 |
D/D |
1,000 |
20,219 |
2.31 |
- |
|
| Cantor Charles R |
Chief Scientific Officer |
• – – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,101 |
7,543 |
|
- |
|
| Lindsay Ronald M |
Exec VP, R&D |
• • – |
2012-02-07 |
4 |
D |
$4.92 |
$15,897 |
D/D |
(3,231) |
67,243 |
|
- |
|
376 Records found
|
|
Page 6 of 16 |
|
|
